LONDON, March 30 (Reuters) - Britain’s SR Pharma Plc (SPA.L: Quote, Profile , Research) said on Friday it was changing its name to Silence Therapeutics to ride better one of the hottest new waves in biotechnology, RNA interference.
LONDON, March 30 (Reuters) - Britain’s SR Pharma Plc (SPA.L: Quote, Profile , Research) said on Friday it was changing its name to Silence Therapeutics to ride better one of the hottest new waves in biotechnology, RNA interference.